| B20 |
Human immunodeficiency virus (HIV) disease |
0—20 |
| C96.0 |
Multifocal and multisystemic Langerhans-cell histiocytosis |
0—64 |
| C96.5 |
Multifocal and unisystemic Langerhans-cell histiocytosis |
0—64 |
| C96.6 |
Unifocal Langerhans-cell histiocytosis |
0—64 |
| D61.01 |
Constitutional (pure) red blood cell aplasia |
0—20 |
| D61.09 |
Other constitutional aplastic anemia |
0—20 |
| D66 |
Hereditary factor VIII deficiency |
0—64 |
| D67 |
Hereditary factor IX deficiency |
0—64 |
| D68.00 |
Von Willebrand disease, unspecified |
0—64 |
| D68.01 |
Von Willebrand disease, type 1 |
0—64 |
| D68.020 |
Von Willebrand disease, type 2A |
0—64 |
| D68.021 |
Von Willebrand disease, type 2B |
0—64 |
| D68.022 |
Von Willebrand disease, type 2M |
0—64 |
| D68.023 |
Von Willebrand disease, type 2N |
0—64 |
| D68.029 |
Von Willebrand disease, type 2, unspecified |
0—64 |
| D68.03 |
Von Willebrand disease, type 3 |
0—64 |
| D68.04 |
Acquired von Willebrand disease |
0—64 |
| D68.09 |
Other von Willebrand disease |
0—64 |
| D68.1 |
Hereditary factor XI deficiency |
0—64 |
| D68.2 |
Hereditary deficiency of other clotting factors |
0—64 |
| E70.0 |
Classical phenylketonuria |
0—20 |
| E70.1 |
Other hyperphenylalaninemias |
0—20 |
| E70.20 |
Disorder of tyrosine metabolism, unspecified |
0—20 |
| E70.21 |
Tyrosinemia |
0—20 |
| E70.29 |
Other disorders of tyrosine metabolism |
0—20 |
| E70.30 |
Albinism, unspecified |
0—20 |
| E70.40 |
Disorders of histidine metabolism, unspecified |
0—20 |
| E70.41 |
Histidinemia |
0—20 |
| E70.49 |
Other disorders of histidine metabolism |
0—20 |
| E70.5 |
Disorders of tryptophan metabolism |
0—20 |
| E70.81 |
Aromatic L-amino acid decarboxylase deficiency |
0—20 |
| E70.89 |
Other disorders of amino-acid metabolism |
0—20 |
| E71.110 |
Isovaleric acidemia |
0—20 |
| E71.111 |
3-methylglutaconic aciduria |
0—20 |
| E71.118 |
Other branched-chain organic acidurias |
0—20 |
| E71.120 |
Methylmalonic acidemia |
0—20 |
| E71.121 |
Propionic acidemia |
0—20 |
| E71.128 |
Other disorders of propionate metabolism |
0—20 |
| E71.19 |
Other disorders of branched-chain amino-acid metabolism |
0—20 |
| E71.2 |
Disorder of branched-chain amino-acid metabolism, unspecified |
0—20 |
| E71.310 |
Long chain/very long chain acyl CoA dehydrogenase deficiency |
0—64 |
| E71.311 |
Medium chain acyl CoA dehydrogenase deficiency |
0—64 |
| E71.312 |
Short chain acyl CoA dehydrogenase deficiency |
0—64 |
| E71.313 |
Glutaric aciduria type II |
0—64 |
| E71.314 |
Muscle carnitine palmitoyltransferase deficiency |
0—64 |
| E71.318 |
Other disorders of fatty-acid oxidation |
0—64 |
| E71.32 |
Disorders of ketone metabolism |
0—64 |
| E71.39 |
Other disorders of fatty-acid metabolism |
0—64 |
| E71.41 |
Primary carnitine deficiency |
0—64 |
| E71.42 |
Carnitine deficiency due to inborn errors of metabolism |
0—64 |
| E71.50 |
Peroxisomal disorder, unspecified |
0—64 |
| E71.510 |
Zellweger syndrome |
0—64 |
| E71.511 |
Neonatal adrenoleukodystrophy |
0—64 |
| E71.518 |
Other disorders of peroxisome biogenesis |
0—64 |
| E71.520 |
Childhood cerebral X-linked adrenoleukodystrophy |
0—64 |
| E71.521 |
Adolescent X-linked adrenoleukodystrophy |
0—64 |
| E71.522 |
Adrenomyeloneuropathy |
0—64 |
| E71.528 |
Other X-linked adrenoleukodystrophy |
0—64 |
| E71.529 |
X-linked adrenoleukodystrophy, unspecified type |
0—64 |
| E71.53 |
Other group 2 peroxisomal disorders |
0—64 |
| E71.540 |
Rhizomelic chondrodysplasia punctata |
0—64 |
| E71.541 |
Zellweger-like syndrome |
0—64 |
| E71.542 |
Other group 3 peroxisomal disorders |
0—64 |
| E71.548 |
Other peroxisomal disorders |
0—64 |
| E72.01 |
Cystinuria |
0—20 |
| E72.02 |
Hartnup’s disease |
0—20 |
| E72.03 |
Lowe’s syndrome |
0—20 |
| E72.04 |
Cystinosis |
0—20 |
| E72.09 |
Other disorders of amino-acid transport |
0—20 |
| E72.11 |
Homocystinuria |
0—20 |
| E72.12 |
Methylenetetrahydrofolate reductase deficiency |
0—20 |
| E72.19 |
Other disorders of sulfur-bearing amino-acid metabolism |
0—20 |
| E72.20 |
Disorder of urea cycle metabolism, unspecified |
0—20 |
| E72.21 |
Argininemia |
0—20 |
| E72.22 |
Arginosuccinic aciduria |
0—20 |
| E72.23 |
Citrullinemia |
0—20 |
| E72.29 |
Other disorders of urea cycle metabolism |
0—20 |
| E72.3 |
Disorders of lysine and hydroxylysine metabolism |
0—20 |
| E72.4 |
Disorders of ornithine metabolism |
0—20 |
| E72.51 |
Non-ketotic hyperglycinemia |
0—20 |
| E72.52 |
Trimethylaminuria |
0—20 |
| E72.53 |
Primary hyperoxaluria |
0—20 |
| E72.59 |
Other disorders of glycine metabolism |
0—20 |
| E72.81 |
Disorders of gamma aminobutyric acid metabolism |
0—20 |
| E72.89 |
Other specified disorders of amino-acid metabolism |
0—20 |
| E74.00 |
Glycogen storage disease, unspecified |
0—20 |
| E74.01 |
von Gierke disease |
0—20 |
| E74.02 |
Pompe disease |
0—20 |
| E74.03 |
Cori disease |
0—20 |
| E74.04 |
McArdle disease |
0—20 |
| E74.09 |
Other glycogen storage disease |
0—20 |
| E74.12 |
Hereditary fructose intolerance |
0—20 |
| E74.19 |
Other disorders of fructose metabolism |
0—20 |
| E74.21 |
Galactosemia |
0—20 |
| E74.29 |
Other disorders of galactose metabolism |
0—20 |
| E74.4 |
Disorders of pyruvate metabolism and gluconeogenesis |
0—20 |
| E75.00 |
GM2 gangliosidosis, unspecified |
0—20 |
| E75.01 |
Sandhoff disease |
0—20 |
| E75.02 |
Tay-Sachs disease |
0—20 |
| E75.09 |
Other GM2 gangliosidosis |
0—20 |
| E75.10 |
Unspecified gangliosidosis |
0—20 |
| E75.11 |
Mucolipidosis IV |
0—20 |
| E75.19 |
Other gangliosidosis |
0—20 |
| E75.21 |
Fabry (-Anderson) disease |
0—20 |
| E75.22 |
Gaucher disease |
0—20 |
| E75.23 |
Krabbe disease |
0—20 |
| E75.242 |
Niemann-Pick disease type C |
0—20 |
| E75.243 |
Niemann-Pick disease type D |
0—20 |
| E75.244 |
Niemann-Pick disease type A/B |
0—20 |
| E75.25 |
Metachromatic leukodystrophy |
0—20 |
| E75.26 |
Sulfatase deficiency |
0—20 |
| E75.29 |
Other sphingolipidosis |
0—20 |
| E75.3 |
Sphingolipidosis, unspecified |
0—20 |
| E75.4 |
Neuronal ceroid lipofuscinosis |
0—20 |
| E75.5 |
Other lipid storage disorders |
0—20 |
| E76.01 |
Hurler’s syndrome |
0—64 |
| E76.02 |
Hurler-Scheie syndrome |
0—64 |
| E76.03 |
Scheie’s syndrome |
0—64 |
| E76.1 |
Mucopolysaccharidosis, type II |
0—64 |
| E76.210 |
Morquio A mucopolysaccharidoses |
0—64 |
| E76.211 |
Morquio B mucopolysaccharidoses |
0—64 |
| E76.219 |
Morquio mucopolysaccharidoses, unspecified |
0—64 |
| E76.22 |
Sanfilippo mucopolysaccharidoses |
0—64 |
| E76.29 |
Other mucopolysaccharidoses |
0—64 |
| E76.3 |
Mucopolysaccharidosis, unspecified |
0—64 |
| E76.8 |
Other disorders of glucosaminoglycan metabolism |
0—64 |
| E77.0 |
Defects in post-translational mod of lysosomal enzymes |
0—20 |
| E77.1 |
Defects in glycoprotein degradation |
0—20 |
| E77.8 |
Other disorders of glycoprotein metabolism |
0—20 |
| E79.1 |
Lesch-Nyhan syndrome |
0—64 |
| E79.2 |
Myoadenylate deaminase deficiency |
0—64 |
| E79.8 |
Other disorders of purine and pyrimidine metabolism |
0—64 |
| E79.9 |
Disorder of purine and pyrimidine metabolism, unspecified |
0—64 |
| E80.3 |
Defects of catalase and peroxidase |
0—64 |
| E84.0 |
Cystic fibrosis with pulmonary manifestations |
0—64 |
| E84.11 |
Meconium ileus in cystic fibrosis |
0—64 |
| E84.19 |
Cystic fibrosis with other intestinal manifestations |
0—64 |
| E84.8 |
Cystic fibrosis with other manifestations |
0—64 |
| E84.9 |
Cystic fibrosis, unspecified |
0—64 |
| E88.40 |
Mitochondrial metabolism disorder, unspecified |
0—64 |
| E88.41 |
MELAS syndrome |
0—64 |
| E88.42 |
MERRF syndrome |
0—64 |
| E88.49 |
Other mitochondrial metabolism disorders |
0—64 |
| E88.89 |
Other specified metabolic disorders |
0—64 |
| F84.2 |
Rett’s syndrome |
0—20 |
| G11.0 |
Congenital nonprogressive ataxia |
0—20 |
| G11.10 |
Early-onset cerebellar ataxia, unspecified |
0—20 |
| G11.11 |
Friedreich ataxia |
0—20 |
| G11.19 |
Other early-onset cerebellar ataxia |
0—20 |
| G11.2 |
Late-onset cerebellar ataxia |
0—20 |
| G11.3 |
Cerebellar ataxia with defective DNA repair |
0—20 |
| G11.4 |
Hereditary spastic paraplegia |
0—20 |
| G11.8 |
Other hereditary ataxias |
0—20 |
| G11.9 |
Hereditary ataxia, unspecified |
0—20 |
| G12.0 |
Infantile spinal muscular atrophy, type I (Werdnig-Hoffman) |
0—20 |
| G12.1 |
Other inherited spinal muscular atrophy |
0—20 |
| G12.21 |
Amyotrophic lateral sclerosis |
0—20 |
| G12.22 |
Progressive bulbar palsy |
0—20 |
| G12.29 |
Other motor neuron disease |
0—20 |
| G12.8 |
Other spinal muscular atrophies and related syndromes |
0—20 |
| G12.9 |
Spinal muscular atrophy, unspecified |
0—20 |
| G24.1 |
Genetic torsion dystonia |
0—64 |
| G24.8 |
Other dystonia |
0—64 |
| G25.3 |
Myoclonus |
0—5 |
| G25.9 |
Extrapyramidal and movement disorder, unspecified |
0—20 |
| G31.81 |
Alpers disease |
0—20 |
| G31.82 |
Leigh’s disease |
0—20 |
| G31.9 |
Degenerative disease of nervous system, unspecified |
0—20 |
| G32.81 |
Cerebellar ataxia in diseases classified elsewhere |
0—20 |
| G37.0 |
Diffuse sclerosis of central nervous system |
0—64 |
| G37.5 |
Concentric sclerosis (Balo) of central nervous system |
0—64 |
| G71.00 |
Muscular dystrophy, unspecified |
0—64 |
| G71.01 |
Duchenne or Becker muscular dystrophy |
0—64 |
| G71.02 |
Facioscapulohumeral muscular dystrophy |
0—64 |
| G71.031 |
Autosomal dominant limb girdle muscular dystrophy |
0—64 |
| G71.032 |
Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction |
0—64 |
| G71.033 |
Limb girdle muscular dystrophy due to dysferlin dysfunction |
0—64 |
| G71.0340 |
Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified |
0—64 |
| G71.0341 |
Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction |
0—64 |
| G71.0342 |
Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction |
0—64 |
| G71.0349 |
Limb girdle muscular dystrophy due to other sarcoglycan dysfunction |
0—64 |
| G71.035 |
Limb girdle muscular dystrophy due to anoctamin-5 dysfunction |
0—64 |
| G71.038 |
Other limb girdle muscular dystrophy |
0—64 |
| G71.039 |
Limb girdle muscular dystrophy, unspecified |
0—64 |
| G71.09 |
Other specified muscular dystrophies |
0—64 |
| G71.11 |
Myotonic muscular dystrophy |
0—64 |
| G71.20 |
Congenital myopathy, unspecified |
0—64 |
| G71.21 |
Nemaline myopathy |
0—64 |
| G71.220 |
Centronuclear myopathy |
0—64 |
| G71.228 |
Other centronuclear myopathy |
0—64 |
| G71.29 |
Other congenial myopathy |
0—64 |
| G80.0 |
Spastic quadriplegic cerebral palsy |
0—64 |
| G80.1 |
Spastic diplegic cerebral palsy |
0—20 |
| G80.3 |
Athetoid cerebral palsy |
0—64 |
| G82.50 |
Quadriplegia, unspecified |
0—64 |
| G82.51 |
Quadriplegia, C1-C4 complete |
0—64 |
| G82.52 |
Quadriplegia, C1-C4 incomplete |
0—64 |
| G82.53 |
Quadriplegia, C5-C7 complete |
0—64 |
| G82.54 |
Quadriplegia, C5-C7 incomplete |
0—64 |
| G91.0 |
Communicating hydrocephalus |
0—20 |
| G91.1 |
Obstructive hydrocephalus |
0—20 |
| I67.5 |
Moyamoya disease |
0—64 |
| K91.2 |
Postsurgical malabsorption, not elsewhere classified |
0—20 |
| N03.A |
Chronic nephritic syndrome with C3 glomerulonephritis |
0—20 |
| N03.1 |
Chronic nephritic syndrome with focal and segmental glomerular lesions |
0—20 |
| N03.2 |
Chronic nephritic syndrome w diffuse membranous glomrlneph |
0—20 |
| N03.3 |
Chronic neph syndrome w diffuse mesangial prolif glomrlneph |
0—20 |
| N03.4 |
Chronic neph syndrome w diffuse endocaplry prolif glomrlneph |
0—20 |
| N03.5 |
Chronic nephritic syndrome w diffuse mesangiocap glomrlneph |
0—20 |
| N03.6 |
Chronic nephritic syndrome with dense deposit disease |
0—20 |
| N03.7 |
Chronic nephritic syndrome w diffuse crescentic glomrlneph |
0—20 |
| N03.8 |
Chronic nephritic syndrome with other morphologic changes |
0—20 |
| N03.9 |
Chronic nephritic syndrome with unspecified morphologic changes |
0—20 |
| N08 |
Glomerular disorders in diseases classified elsewhere |
0—20 |
| N18.1 |
Chronic kidney disease, stage 1 |
0—20 |
| N18.2 |
Chronic kidney disease, stage 2 (mild) |
0—20 |
| N18.30 |
Chronic kidney disease, stage 3, unspecified |
0—20 |
| N18.31 |
Chronic kidney disease, stage 3a |
0—20 |
| N18.32 |
Chronic kidney disease, stage 3b |
0—20 |
| N18.4 |
Chronic kidney disease, stage 4 (severe) |
0—20 |
| N18.5 |
Chronic kidney disease, stage 5 |
0—20 |
| N18.6 |
End stage renal disease |
0—20 |
| N18.9 |
Chronic kidney disease, unspecified |
0—20 |
| Q01.9 |
Encephalocele, unspecified |
0—20 |
| Q02 |
Microcephaly |
0—20 |
| Q03.0 |
Malformations of aqueduct of Sylvius |
0—20 |
| Q03.1 |
Atresia of foramina of Magendie and Luschka |
0—20 |
| Q03.8 |
Other congenital hydrocephalus |
0—20 |
| Q03.9 |
Congenital hydrocephalus, unspecified |
0—20 |
| Q04.3 |
Other reduction deformities of brain |
0—20 |
| Q04.5 |
Megalencephaly |
0—20 |
| Q04.6 |
Congenital cerebral cysts |
0—20 |
| Q04.8 |
Other specified congenital malformations of brain |
0—20 |
| Q05.0 |
Cervical spina bifida with hydrocephalus |
0—64 |
| Q05.1 |
Thoracic spina bifida with hydrocephalus |
0—64 |
| Q05.2 |
Lumbar spina bifida with hydrocephalus |
0—64 |
| Q05.3 |
Sacral spina bifida with hydrocephalus |
0—64 |
| Q05.4 |
Unspecified spina bifida with hydrocephalus |
0—64 |
| Q05.5 |
Cervical spina bifida without hydrocephalus |
0—64 |
| Q05.6 |
Thoracic spina bifida without hydrocephalus |
0—64 |
| Q05.7 |
Lumbar spina bifida without hydrocephalus |
0—64 |
| Q05.8 |
Sacral spina bifida without hydrocephalus |
0—64 |
| Q05.9 |
Spina bifida, unspecified |
0—64 |
| Q06.0 |
Amyelia |
0—64 |
| Q06.1 |
Hypoplasia and dysplasia of spinal cord |
0—64 |
| Q06.2 |
Diastematomyelia |
0—64 |
| Q06.3 |
Other congenital cauda equina malformations |
0—64 |
| Q06.4 |
Hydromyelia |
0—64 |
| Q06.8 |
Other specified congenital malformations of spinal cord |
0—64 |
| Q07.01 |
Arnold-Chiari syndrome with spina bifida |
0—64 |
| Q07.02 |
Arnold-Chiari syndrome with hydrocephalus |
0—64 |
| Q07.03 |
Arnold-Chiari syndrome with spina bifida and hydrocephalus |
0—64 |
| Q30.1 |
Agenesis and underdevelopment of nose, cleft or absent nose only |
0—5 |
| Q30.2 |
Fissured, notched and cleft nose, cleft or absent nose only |
0—5 |
| Q31.0 |
Web of larynx |
0—20 |
| Q31.8 |
Other congenital malformations of larynx, atresia or agenesis of larynx only |
0—20 |
| Q32.1 |
Other congenital malformations of trachea, atresia or agenesis of trachea only |
0—20 |
| Q32.4 |
Other congenital malformations of bronchus, atresia or agenesis of bronchus only |
0—20 |
| Q33.0 |
Congenital cystic lung |
0—20 |
| Q33.2 |
Sequestration of lung |
0—20 |
| Q33.3 |
Agenesis of lung |
0—20 |
| Q33.6 |
Congenital hypoplasia and dysplasia of lung |
0—20 |
| Q35.1 |
Cleft hard palate |
0—20 |
| Q35.3 |
Cleft soft palate |
0—20 |
| Q35.5 |
Cleft hard palate with cleft soft palate |
0—20 |
| Q35.9 |
Cleft palate, unspecified |
0—20 |
| Q37.0 |
Cleft hard palate with bilateral cleft lip |
0—20 |
| Q37.1 |
Cleft hard palate with unilateral cleft lip |
0—20 |
| Q37.2 |
Cleft soft palate with bilateral cleft lip |
0—20 |
| Q37.3 |
Cleft soft palate with unilateral cleft lip |
0—20 |
| Q37.4 |
Cleft hard and soft palate with bilateral cleft lip |
0—20 |
| Q37.5 |
Cleft hard and soft palate with unilateral cleft lip |
0—20 |
| Q37.8 |
Unspecified cleft palate with bilateral cleft lip |
0—20 |
| Q37.9 |
Unspecified cleft palate with unilateral cleft lip |
0—20 |
| Q39.0 |
Atresia of esophagus without fistula |
0—3 |
| Q39.1 |
Atresia of esophagus with tracheo-esophageal fistula |
0—3 |
| Q39.2 |
Congenital tracheo-esophageal fistula without atresia |
0—3 |
| Q39.3 |
Congenital stenosis and stricture of esophagus |
0—3 |
| Q39.4 |
Esophageal web |
0—3 |
| Q42.0 |
Congenital absence, atresia and stenosis of rectum with fistula |
0—5 |
| Q42.1 |
Congen absence, atresia and stenosis of rectum without fistula |
0—5 |
| Q42.2 |
Congenital absence, atresia and stenosis of anus with fistula |
0—5 |
| Q42.3 |
Congenital absence, atresia and stenosis of anus without fistula |
0—5 |
| Q42.8 |
Congenital absence, atresia and stenosis of other parts of large intestine |
0—5 |
| Q42.9 |
Congenital absence, atresia and stenosis of large intestine, part unspecified |
0—5 |
| Q43.1 |
Hirschsprung’s disease |
0—15 |
| Q44.2 |
Atresia of bile ducts |
0—20 |
| Q44.3 |
Congenital stenosis and stricture of bile ducts |
0—20 |
| Q44.6 |
Cystic disease of liver |
0—20 |
| Q45.0 |
Agenesis, aplasia and hypoplasia of pancreas |
0—5 |
| Q45.1 |
Annular pancreas |
0—5 |
| Q45.3 |
Other congenital malformations of pancreas and pancreatic duct |
0—5 |
| Q45.8 |
Other specified congenital malformations of digestive system |
0—10 |
| Q60.1 |
Renal agenesis, bilateral |
0—20 |
| Q60.4 |
Renal hypoplasia, bilateral |
0—20 |
| Q60.6 |
Potter’s syndrome, with bilateral renal agenesis only |
0—20 |
| Q61.02 |
Congenital multiple renal cysts, bilateral only |
0—20 |
| Q61.19 |
Other polycystic kidney, infantile type, bilateral only |
0—20 |
| Q61.2 |
Polycystic kidney, adult type, bilateral only |
0—20 |
| Q61.3 |
Polycystic kidney, unspecified, bilateral only |
0—20 |
| Q61.4 |
Renal dysplasia, bilateral only |
0—20 |
| Q61.5 |
Medullary cystic kidney, bilateral only |
0—20 |
| Q61.9 |
Cystic kidney disease, unspecified, bilateral only |
0—20 |
| Q64.10 |
Exstrophy of urinary bladder, unspecified |
0—20 |
| Q64.12 |
Cloacal extrophy of urinary bladder |
0—20 |
| Q64.19 |
Other exstrophy of urinary bladder |
0—20 |
| Q75.0 |
Craniosynostosis |
0—20 |
| Q75.1 |
Craniofacial dysostosis |
0—20 |
| Q75.2 |
Hypertelorism |
0—20 |
| Q75.4 |
Mandibulofacial dysostosis |
0—20 |
| Q75.5 |
Oculomandibular dysostosis |
0—20 |
| Q75.8 |
Other congenital malformations of skull and face bones |
0—20 |
| Q77.4 |
Achondroplasia |
0—1 |
| Q77.6 |
Chondroectodermal dysplasia |
0—1 |
| Q77.8 |
Other osteochondrodysplasia with defects of growth of tubular bones and spine |
0—1 |
| Q78.0 |
Osteogenesis imperfecta |
0—20 |
| Q78.1 |
Polyostotic fibrous dysplasia |
0—1 |
| Q78.2 |
Osteopetrosis |
0—1 |
| Q78.3 |
Progressive diaphyseal dysplasia |
0—1 |
| Q78.4 |
Enchondromatosis |
0—1 |
| Q78.6 |
Multiple congenital exostoses |
0—1 |
| Q78.8 |
Other specified osteochondrodysplasias |
0—1 |
| Q78.9 |
Osteochondrodysplasia, unspecified |
0—1 |
| Q79.0 |
Congenital diaphragmatic hernia |
0—1 |
| Q79.1 |
Other congenital malformations of diaphragm |
0—1 |
| Q79.2 |
Exomphalos |
0—1 |
| Q79.3 |
Gastroschisis |
0—1 |
| Q79.4 |
Prune belly syndrome |
0—1 |
| Q79.59 |
Other congenital malformations of abdominal wall |
0—1 |
| Q89.7 |
Multiple congenital malformations, not elsewhere classified |
0—10 |
| R75 |
Inconclusive laboratory evidence of HIV |
0—12 months |
| Z21 |
Asymptomatic human immunodeficiency virus infection status |
0—20 |
| Z99.11 |
Dependence on respirator (ventilator) status |
1—64 |
| Z99.2 |
Dependence on renal dialysis |
21—64 |